CompletedNCT04393987
Official study titleEffect Of Treatment Compliance Training Given To Patients With Bipolar Disorder On Treatment Compliance, Social Functioning, And Quality Of Life
This study has finished and is no longer accepting participants.
In UşakBipolarityBehavioural studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Uşak University
TerminatedNCT02936466
Official study titleEvaluation of a Serious Game for Patients With Bipolar Disorder Involved in a Psychoeducation Group
This study ended early.
In MontpellierBipolarityBehavioural studyAges 18+
- Countries
- France
- Sponsor
- University Hospital, Montpellier
CompletedNCT00182013
Official study titleOpen-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 6–18
- Countries
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01272531
Official study titlePharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoBipolarityObservational studyAges 18+
- Countries
- United States, Canada, Norway
- Sponsor
- University of California, San Diego
CompletedNCT02241863
Official study titleThe Effect of a Theory Based Educational Intervention on Medication Adherence to and Removes of Related Barriers in Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including AhvāzBipolarityBehavioural studyAges 18+
- Countries
- Iran
- Sponsor
- Qazvin University Of Medical Sciences
CompletedNCT07404943
Official study titleThe Effect of Telenursing Counseling on Functioning and Treatment Adherence Levels in Individuals With Bipolar Disorder
This study has finished and is no longer accepting participants.
In KütahyaBipolarityBehavioural studyAges 18+
- Countries
- Türkiye
- Sponsor
- Didem Ayhan
CompletedNCT04834999
Official study titleValidation and Transcultural Adaptation of Instruments Used in a Clinical Trial on Patients With Bipolar Disorder in Rwanda
This study has finished and is no longer accepting participants.
In KigaliBipolarityObservational studyAges 18+
- Countries
- Rwanda
- Sponsor
- University of Aarhus
CompletedNCT00159744
Official study titleA Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501004 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00159796
Official study titleA Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501005 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00195780
Official study titleAn Open-Label Study to Evaluate the Safety of Depakote ER in the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- Abbott
CompletedNCT00250367
What is this study about?This study evaluated the safety and effectiveness of risperidone for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–65
- Countries
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
CompletedNCT00257075
Official study titleThe Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Episodes Associated With Bipolar I Disorder.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.